INS and MODY: It has been reported that a mutation in this gene causes a defect in the nuclear factor kappa-light-chain enhancer of the activated β-cells (NF-κB) transcription factor, leading to the reduced structural stability of insulin molecule associated with a very rare form of the MODY subtype, designated as MODY 10.